Serum levels of coenzyme Q10 in patients with multiple sclerosis

Acta Neurologica Scandinavica

Volumn 101, Issue 3, 2000, Pages 209-211

  De Bustos, F ^a   Jiménez Jiménez, Félix Javier ^b,d   Molina, J A ^a   Gomez Escalonilla C ^a   De Andres C ^c   Del Hoyo, P ^a   Zurdo, M ^b   Tallon Barranco A ^b   Berbel, A ^a   Porta Etessam, J ^a   Parrilla, G ^a   Arenas, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d NONE   (Spain)

Author keywords

Coenzyme Q10; Multiple sclerosis; Serum levels

Indexed keywords

BIOCHEMICAL MARKER; CHOLESTEROL; UBIDECARENONE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTIPLE SCLEROSIS;

ADULT; BIOLOGICAL MARKERS; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MULTIPLE SCLEROSIS; UBIQUINONE;

EID: 0034001366     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101003209.x     Document Type: Article

References (18)

1. 1. Wynn DR, Rodríguez M, O'Fallon WM, Kurland LT. Update on the epidemiology of multiple sclerosis. Mayo Clin Proc 1989;64:808-17.
2. 2. Martyn C. The epidemiology of multiple sclerosis. In: Matthews WB, Compston A, Allen IV, Martyn CN, eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991:3-40.
3. 3. Allen I. Aetiological hypotheses for multiple sclerosis: evidence from human and experimental diseases. In: Matthews WB, Compston A, Allen IV, Martyn CN, eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991:379-90.
4. 4. Poser CM. Multiple sclerosis. Observations and reflections a personal memoir. J Neurol Sci 1992;107:127-40.
5. 5. Dudek I, Zagorski T, Liskiewicz J, Kedziora J, Chmielewski H. Effect of gamma radiation on selected indicators of oxygen metabolism in erythrocytes of patients with multiple sclerosis. Neurol Neurochir Pol 1992;26:34-9.
6. 6. Toshniwal PK, Zarling EJ. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem Res 1992;17: 205-7.
7. 7. Langemann H, Kabiersch A, Newcombe J. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol 1992; 32:248-52.
8. 8. Newcombe J, Li H, Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 1994;20:152-62.
9. 9. Calabrese V, Raffaele R, Cosentino E, Rizza V. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Int J Clin Pharmacol Res 1994;14:119-23.
10. 10. Bongarzone ER, Pasquini JM, Soto EF. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res 1995; 41:213-21.
11. 11. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Ann Neurol 1995; 42:261-4.
12. 12. Steen G, Axelsson H, Bowallius M, Holthuis N, Molander BM. Isoprenoid biosynthesis in multiple sclerosis. II. A possible role of NADPH. Acta Neurol Scand 1987;76:461-7.
13. 13. Steen G, Axelsson H, Bowallius M, Holthuis N, Molander BM. Isoprenoid biosynthesis in multiple sclerosis. Acta Neurol Scand 1985;72:328-35.
14. 14. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. 10 in human plasma as a possible marker of oxidative stress. J Lipid Res 1996;37:67-75.
16. 10 in patients with Parkinson's disease. J Neural Transm. (In press.)
17. 17. Moreu E, Molinero LM, Fernández E. R-Sigma: Base de datos bioestadistica para un ordenador personal. Madrid: Horus Hardware, 1990.
18. 18. Jiménez-Jiménez FJ, de Bustos F, Molina JA et al. Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. Neurosci Lett 1998; 249:65-7.